← Back to INM

InMed Pharmaceuticals Inc. - Common Shares financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSMar 2026Filed 02/07/2026Dec 2025Filed 02/07/2026Sep 2025Filed 02/07/2026Mar 2025Filed 02/07/2026Dec 2024Filed 02/07/2026Sep 2024Filed 02/07/2026Mar 2024Filed 12/05/2025Dec 2023Filed 12/05/2025
$0.8$1.1$1.3$1.1$1.3$1.2$1.2
−$3−$2−$1.7−$2.1−$2.6−$1.7−$1.7−$1.5
−$0.73−$0.51−$0.44−$1.94−$3.64−$2.71−$3.58−$3.71
4441.10.70.60.50.4

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.